Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Topic: New Perspectives on the Diagnosis and Management of HCC

A special issue of Hepatoma Research

ISSN 2454-2520 (Online), ISSN 2394-5079 (Print)

Submission deadline: 31 Oct 2019

Guest Editor(s)

  • Dalbir Singh Sandhu, MD
    Assistant Professor of Medicine, Case Western Reserve University; Director of Endoscopy, Cleveland Clinic, Akron General 1, Akron General Ave, Akron, OH, USA.


Special Issue Introduction

Hepatocellular carcinoma (HCC) is the 5th most common cancer and the third leading cause of cancer related deaths worldwide as estimated by World health Organization. An increased trend in mortality rates related to HCC has been observed in most countries over recent decades. Apart from chronic viral illnesses (Hepatitis B and Hepatitis C) and alcohol liver disease, non-alcoholic fatty liver disease is emerging as an important etiology for the development of HCC. Despite our increased understanding about the molecular pathogenesis of HCC, the diagnosis and management of HCC still poses a challenge to clinicians. Recent years have noted a surge in newer diagnostic modalities (imaging, molecular markers, etc.) for HCC. The treatment approaches including newer molecular targets especially for advanced HCC are also rapidly evolving. This special issue will focus on the new perspectives in the diagnosis and management of HCC.


Submission Deadline

31 Oct 2019

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 31 Oct 2019
Contacts: Haidi Ding, Assistant Editor,

Published Articles

© 2016-2022 OAE Publishing Inc., except certain content provided by third parties